Can affordability and innovation coexist for medicines?
Improved transparency is essential to determine what is fair writes Allison Colbert et al.
Defining the concept of fair pricing for medicines
Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers
Strategies to achieve fairer prices for generic and biosimilar medicines
Early market entry and rapid uptake of quality assured generic and biosimilars are key to improving access to medicines, say Alessandra Ferrario and colleagues
Pricing of pharmaceuticals is becoming a major challenge for health systems
Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable, argue Steven Morgan and colleagues
New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines
For research and development to systematically deliver fairly priced medicines, new approaches to financing and organisation are needed, and affordability must be integrated into push, pull, and pooling mechanisms, say Fatima Suleman and colleagues
Price transparency is a step towards sustainable access in middle income countries
Tania Cernuschi and colleagues show how information from the Market Information for Access to Vaccines database is strengthening the ability of middle income countries to negotiate with vaccine producers
Medicines with one seller and many buyers: strategies to increase the power of the payer
Andrew Rintoul and colleagues argue that collaboration and transparency increase the market power of buyers who face a monopoly